Heat-shock-protein-27(hsp27) expression in ovarian carcinoma: Relation in response to chemotherapy and prognosis

International Journal of Cancer

Volumn 84, Issue 3, 1999, Pages 234-238

  Arts, Henriette J G ^b   Hollema, Harry ^b   Lemstra, Willy ^b   Willemse, Pax H B ^b   De Vries, Elisabeth G E ^b   Kampinga, Harm H ^b   Van Der Zee, Ate G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HEAT SHOCK PROTEIN 27; HEXAMETHONIUM; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RESISTANCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 0032990651     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990621)84:3<234::AID-IJC6>3.0.CO;2-9     Document Type: Article

References (24)

1. BUCHNER, J., Supervising the fold: functional principles of molecular chaperones. FASEB J., 10, 10-19 (1996).
2. CIOCCA, D.R., FUQUA, S.A.W., LOCK-LIM, S., TOFT, D.O., WELCH, W.J. and MCGUIRE, W.L., Response of human breast-cancer cells to heat shock and chemotherapeutic drugs. Cancer Res., 52, 3648-3654 (1992).
3. DUNTON, C.J., New options for the treatment of advanced ovarian cancer. Semin. Oncol., 24, S5-S2S511 (1997).
4. EMANUELS, A., HOLLEMA, H. and KOUDSTAAL, J., Autoclave heating: an alternative method for microwaving? Europ. J. Morphol., 32, 337-340 (1994).
5. INTERNATIONAL FEDERATION OF GYNECOLOGY AND OBSTETRICS, Changes in definitions of clinical staging for cancer of the cervix and ovary. Amer. J. Obstet. Gynecol., 156, 236-241 (1987).
6. GEISLER, J.P., GEISLER, H.E., TAMMELA, J., WIEMANN, M.C., ZHOU, Z., MILLER, G.A. and CRABTREE, W., Heat-shock protein 27: an independent prognostic indicator of survival in patients with epithelial ovarian carcinoma. Gynecol. Oncol., 69, 14-16 (1998).
7. GERMAIN, I., TETU, B., BRISSON, J., MONDER, M. and CHERIAN, M.G., Markers of chemoresistance in ovarian carcinomas: an immunohistochemical study of 86 cases. Int. J. Gynecol. Pathol., 15, 54-62 (1996).
8. HUOT, J., ROY, G., LAMBERT, H., CHRETIEN, P. and LANDRY, J., Increased survival after treatments with anti-cancer agents of Chinese hamster cells expressing the human Mt 27,000 heat-shock protein. Cancer Res., 51, 5245-5252 (1991).
9. KRISTENSEN, G.B. and TROPE, C., Epithelial ovarian carcinoma. Lancet, 349, 113-117 (1997).
10. LANGDON, S.P., RABIASZ, G.J., HIRST, G.L., KING, R.J.B., HAWKINS, R.A., SMYTH, J.F. and MILLER, W.R., Expression of the heat-shock protein hsp27 in human ovarian cancer. Clin. Cancer Res., 1, 1603-1609 (1995).
11. MAIRESSE, N., HORMAN, S., MOSSELMANS, R. and GALAND, P., Anti-sense inhibition of the 27-kDa heat-shock-protein production affects growth rate and cytoskeletal organization in MCF-7 cells. Cell. Biol. Int., 20, 205-212 (1996).
12. MEHLEN, P., KRETZ-REMY, C., PREVILLE, X. and ARRIGO, A.P., Human hsp27, Drosophila hsp27 and human alpha-B-crystallin-expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNF-alpha-induced cell death. EMBO J., 15, 2695-2706 (1996).
13. MEIJER, C., MULDER, N.H. and DE VRIES, E.G.E., The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin. Cancer Treat. Rev., 17, 389-407 (1990).
14. OESTERREICH, S., WENG, C.N., QIU, M., HILSENBECK, S.G., OSBORNE, C.K. and FUQUA, S.A.W., The small heat-shock protein hsp27 is correlated with growth and drug resistance in human breast-cancer cell lines. Cancer Res., 53, 4443-4448 (1993).
15. PARKER, S.L., TONG, T., BOLDEN, S. and WINGO, P.A., Cancer statistics 1997. CA Cancer J. Clin., 47, 5-27 (1997).
16. RICHARDS, E.H., HICKEY, E., WEBER, L. and MASTERS, J.R.W., Effect of over-expression of the small heat-shock protein hsp27 on the heat and drug sensitivities of human testis-tumor cells. Cancer Res., 56, 2446-2451 (1996).
17. SEROV, S.F., SCULLY, R.E. and SOBIN, L.H., Histological typing of ovarian tumors, pp. 17, 18. WHO Geneva (1973).
18. SEYMOUR, I., BEZWODA, W.R. and MEYER, K., Tumor factors predicting for prognosis in metastatic breast cancer. Cancer, 66, 2390-2394 (1990).
19. SOBRE, B., FRANKENDAL, B. and VERESS, B., Importance of histological grade in the prognosis of epithelial ovarian carcinomas. Obstet. Gynecol., 59, 567-573 (1982).
20. STORM, F.K., MAHVI, D.M. and GILCHRIST, K.W., Heat-shock-protein-27 over-expression in breast-cancer lymph-node metastasis. Ann. Surg. Oncol., 3, 570-573 (1996).
21. THOR, A., BENZ, C., MOORE, I.D., GOLDMAN, E., EDGERTON, S., LANDRY, J., SCHWARTZ, L., MAYALL, B., HICKEY, E. and WEBER, L.A., Stress-response-protein(srp-27) determination in primary human breast carcinomas: clinical, histologic and prognostic correlations. J. nat. Cancer Inst., 83, 170-178 (1991).
22. UOZAKI, H., HORIUCHI, H., ISHIDA, T., IIJIMA, T., IMAMURA, T. and MACHINAMI, R., Over-expression of resistance-related proteins (metallothioneins, glutathione-S-transferase Pi, heat-shock protein 27 and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis. Cancer, 79, 2336-2344 (1997).
23. VAN DER ZEE, A.G.J., HOLLEMA, H.H., SUURMEIJER, A.J.H., WILLEMSE, P.H.B., KRANS, M., SLUITER, W.J., AALDERS, J.G. and DE VRIES, E.G.E., P-glycoprotein, glutathione S-transferase (GST) pi, c-erbB-2 and p53: new prognostic factors in advanced-stage ovarian cancer. J. clin. Oncol., 13, 70-78 (1995).
24. WORLD HEALTH ORGANIZATION, Handbook on reporting results of cancer treatment. WHO Offset Publication 48, Nijhoff, The Hague (1979).